Vimarsana
Biggest News Aggregation in the World

Page 2 - Jared Rutter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jared Rutter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jared Rutter Today - Breaking & Trending Today

Biological Network Helps Body Adapt to Stresses on Health - Vimarsana News

Biological Network Helps Body Adapt to Stresses on Health

Scientists at University of Utah Health led research that opens up a whole new world within our cells. Their study, published in Science, uncovers a vast network of interactions that assist cells in adjusting in real time to withstand stresses on our health.

Source: utah.edu
Fasting boosts stem cells' regenerative capacity | MIT News | Massachusetts Institute of Technology - Vimarsana News

Fasting boosts stem cells' regenerative capacity | MIT News | Massachusetts Institute of Technology

Age-related declines in stem cell function can be reversed by a 24-hour fast, according to a new study from MIT. Biologists found fasting dramatically improves stem cells’ ability to regenerate, in both aged and young mice.

Source: mit.edu
On the Right Side of Being Wrong - Vimarsana News

On the Right Side of Being Wrong

Spurred by the so-called replication crisis, researchers are embracing a new culture of transparency.

A biotech startup's hunt for elusive disease targets scores $60M for drug R&D - Vimarsana News

A biotech startup's hunt for elusive disease targets scores $60M for drug R&D

Atavistik Bio is one of several companies discovering and developing drugs that work by allostery, binding to less obvious sites of a target protein. Acting CEO John Josey said the startup aims to stand apart with its focus on understanding metabolic interactions, a path less trodden by others in allosteric drug discovery.

PAQ Therapeutics Launches with $30 Million Series A to Develop Novel Therapies through Autophagy-Dependent Degradation - Vimarsana News

PAQ Therapeutics Launches with $30 Million Series A to Develop Novel Therapies through Autophagy-Dependent Degradation

Share this article Share this article CAMBRIDGE, Mass., July 15, 2021 /PRNewswire/ -- PAQ Therapeutics, a biotechnology company pioneering a new approach to restoring heath and curing disease through autophagy, today announced the completion of its $30 million Series A financing. PAQ's approach and technology expands the therapeutic potential of autophagy - the body's most versatile mechanism for natural cellular degradation – to target not only disease-causing proteins but lipids, pathogens and other substrates with the goal of restoring health. Sherpa Healthcare Partners led the Series A...